Does SOTORASIB Cause Transaminases increased? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Transaminases increased have been filed in association with SOTORASIB (LUMAKRAS). This represents 0.4% of all adverse event reports for SOTORASIB.
11
Reports of Transaminases increased with SOTORASIB
0.4%
of all SOTORASIB reports
2
Deaths
2
Hospitalizations
How Dangerous Is Transaminases increased From SOTORASIB?
Of the 11 reports, 2 (18.2%) resulted in death, 2 (18.2%) required hospitalization.
Is Transaminases increased Listed in the Official Label?
Yes, Transaminases increased is listed as a known adverse reaction in the official FDA drug label for SOTORASIB.
What Other Side Effects Does SOTORASIB Cause?
Non-small cell lung cancer (483)
Death (319)
Disease progression (314)
Diarrhoea (284)
Off label use (193)
Nausea (98)
Non-small cell lung cancer metastatic (93)
Hepatotoxicity (91)
Fatigue (87)
Hepatic function abnormal (80)
What Other Drugs Cause Transaminases increased?
METHOTREXATE (1,236)
ACETAMINOPHEN (929)
ATORVASTATIN (472)
RITUXIMAB (448)
CYCLOPHOSPHAMIDE (401)
PREDNISONE (362)
ADALIMUMAB (340)
PACLITAXEL (333)
ROSUVASTATIN (324)
CARBOPLATIN (319)
Which SOTORASIB Alternatives Have Lower Transaminases increased Risk?
SOTORASIB vs SOTROVIMAB
SOTORASIB vs SOVALDI
SOTORASIB vs SOYBEAN OIL
SOTORASIB vs SPARSENTAN
SOTORASIB vs SPARTALIZUMAB